1. Home
  2. ACET vs GOCO Comparison

ACET vs GOCO Comparison

Compare ACET & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.50

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$2.99

Market Cap

70.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
GOCO
Founded
1947
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
93.5M
70.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ACET
GOCO
Price
$0.50
$2.99
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$8.50
$5.00
AVG Volume (30 Days)
2.3M
37.9K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$738,338,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.56
52 Week Low
$0.45
$2.17
52 Week High
$1.11
$21.00

Technical Indicators

Market Signals
Indicator
ACET
GOCO
Relative Strength Index (RSI) 33.08 45.69
Support Level $0.50 $2.80
Resistance Level $0.59 $3.41
Average True Range (ATR) 0.05 0.22
MACD 0.00 0.09
Stochastic Oscillator 4.20 51.45

Price Performance

Historical Comparison
ACET
GOCO

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: